Name
CALF-E
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CALF-E
Name
Alternate Names
Alesse
Brevicon
Chee-O-Gen
Chee-O-Genf
Component of Brevicon
Component of Demulan
Component of Levlen
Component of Lo/Ovral
Component of Loestrin
Component of Lynoral#
Component of Modicon
Component of Nordette
Component of Norethrin 1/35E
Component of Norlestrin
Cyclen
Desogen
Diogyn E
Dyloform
Esteed
Estigyn
Estinyl
Eston-E
Estoral
Estrostep
Ethidol
Ethinoral#
Ethinyl Estradiol
Ethinyloestradiol
Eticyclin
Eticylol#
Etinestrol
Feminone
Gencept
Genora
Ginestrene
Halodrin
Inestra
Jenest
Levlen
Levora
Lo/Ovral
Loestrin
Marvelon
Menolyn
Microfollin
Min-Ovral
Minestrin
Mircette
Modicon
Necon
Nee
Nelova
Nelulen
Neo-Mens
Norcept-E
Norinyl
Novestrol
Oradiol
Orestralyn
Ortho Cyclen
Ortho Tro-Cyclen
Ortho-Cept
Ortho-Novum
Ovcon
Ovral
Palonyl Perovex
Preven
Spanestrin
Tri-Cyclen
Tri-Levlen
Tri-Norinyl
Triphasil
Triquilar
Trivora
Zovia
Abbreviations
None
Category
Hormones and hormonal mechanisms
Subcategory
Estrogen. Probably not cancer directed--verify with attending MD.
NSC Number
010973
10973
Primary Site
None
Histology
None
Remarks
An orally effective semisynthetic derivative of estradiol, one of the most potent estrogens. It is a component of many oral contraceptives and is also used in estrogen replacement therapy. Not found in Drugdex drug evaluation.
Coding
This drug should be coded
Name
Alternate Names
5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596
Abbreviations
5-FU
5FU
FU
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
019893
19893
Primary Site
Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Hepatoma
Ovarian cancer
Histology
None
Remarks
Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
Name
Alternate Names
Calcium folinate
Calcium leucovorin
Calcium leucovorin rescue
Citrovorum Factor
Citrovorum factor rescue
Folic acid
Folinic Acid
Lederfoline
Leucosar
Leucovorin Calcium
Leucovorin rescue
Wellcovorin
Abbreviations
C.F.
CF
CL
Category
Ancillary Agent
Subcategory
None
NSC Number
3590
003590
Primary Site
None
Histology
None
Remarks
The pharmacologically active form of folic acid. FDA approved uses as 1st line colorectal carcinoma in combination with 5-FU and to diminish methotrexate toxicity.
Coding
This drug should NOT be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded